Literature DB >> 23428845

The role of fascin in migration and invasion of urothelial carcinoma of the bladder.

Jian-bin Bi1, Yuyan Zhu, Xue-lei Chen, Meng Yu, Yu-xi Zhang, Bing-xun Li, Jia-wei Sun, Hai-lin Shen, Chui-ze Kong.   

Abstract

INTRODUCTION: To investigate the roles of fascin in migration and invasiveness in bladder urothelial carcinoma.
MATERIALS AND METHODS: Immunohistochemical detection of fascin in urothelial carcinoma samples and inhibition the expression of fascin in the urothelial carcinoma cell line were performed, then the differences in cell behaviors before and after silencing of the fascin gene were tested.
RESULTS: In our study, we found that overexpression of fascin was more frequent in urothelial carcinoma tissues (p < 0.001). Fascin expression was positively correlated with histological grade (p = 0.024) and pT stage (p < 0.001). After transfection of fascin shRNA, the expressions of fascin in 5637 cells and BIU87 cells were efficiently decreased according to real-time RT-PCR and Western blot analysis. When fascin was inhibited, a significant decrease in migration and invasion, and increase in adhesion were observed in 5637 cells and BIU87 cells. However, there was no significant change in the proliferation of 5637 cells or BIU87 cells with or without inhibition of the fascin gene.
CONCLUSIONS: Fascin expression can be used as a predictor for transformation and progression of urothelial carcinoma, and reduction of fascin levels may represent a novel therapeutic strategy for urothelial carcinoma of the bladder.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428845     DOI: 10.1159/000346559

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

Review 1.  FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Authors:  Zhongxun Li; Jiao Shi; Nannan Zhang; Xiwang Zheng; Yukun Jin; Shuxin Wen; Wanglai Hu; Yongyan Wu; Wei Gao
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

2.  Prognostic significance of FSCN family in multiple myeloma.

Authors:  Cong Deng; Chaozeng Si; Xu Ye; Qiang Zhou; Tiansheng Zeng; Zeyong Huang; Wenhui Huang; Pei Zhu; Qingfu Zhong; Zhihua Wu; Huoyan Zhu; Qing Lin; Wenjuan Zhang; Lin Fu; Yongjiang Zheng; Tingting Qian
Journal:  J Cancer       Date:  2021-01-30       Impact factor: 4.207

3.  Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling.

Authors:  Donghao Shang; Yuting Liu; Jian Zhang; Xinyi Hu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

4.  Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Authors:  Priscila Campioni Rodrigues; Iris Sawazaki-Calone; Carine Ervolino de Oliveira; Carolina Carneiro Soares Macedo; Mauricio Rocha Dourado; Nilva K Cervigne; Marcia Costa Miguel; Andreia Ferreira do Carmo; Daniel W Lambert; Edgard Graner; Sabrina Daniela da Silva; Moulay A Alaoui-Jamali; Adriana Franco Paes Leme; Tuula A Salo; Ricardo D Coletta
Journal:  Oncotarget       Date:  2017-08-19

5.  The meta and bioinformatics analysis of fascin expression in gastric cancer: a potential marker for aggressiveness and worse prognosis.

Authors:  Hua-Chuan Zheng; Shuang Zhao
Journal:  Oncotarget       Date:  2017-11-06

6.  CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.

Authors:  Fei Xie; Chao Huang; Feng Liu; Hui Zhang; Xingyuan Xiao; Jiayin Sun; Xiaoping Zhang; Guosong Jiang
Journal:  Mol Cancer       Date:  2021-04-14       Impact factor: 27.401

7.  Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion.

Authors:  Shilong Zheng; Qiu Zhong; Yulan Xi; Madhusoodanan Mottamal; Qiang Zhang; Richard L Schroeder; Jayalakshmi Sridhar; Ling He; Harris McFerrin; Guangdi Wang
Journal:  J Med Chem       Date:  2014-07-18       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.